Diagonal Bio
0,026
SEK
+5,31 %
DIABIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 investorer følger denne virksomhed
+5,31%
-25,22%
+100%
-16,5%
-87,94%
-89,36%
-99,25%
-
-99,52%
Diagonal Bio operates in the biotechnology industry. The company is developing a platform under the name Panviral to detect and diagnose small sections of pathogen genomes, such as viruses, bacteria, and fungi. In addition to the main business, service and associated ancillary services are also offered. The largest operations take place in Sweden with headquarter in Lund.
Læs mereMarkedsværdi
10,34 mio. SEK
Aktieomsætning
18,89 t SEK
Omsætning
20 t
EBIT %
-57.850 %
P/E
-
Udbytteafkast, %
-
Finanskalender
25.2
2025
Årsrapport '24
14.5
2025
Delårsrapport Q1'25
20.5
2025
Generalforsamling '24
ViserAlle indholdstyper
Diagonal Bio AB: Nomination Committee appointed for Diagonal Bio
Diagonal Bio AB: Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools